Assessment of New Biomarkers in the Management and Triage of Patients With Chest Pain and Suspicion of Non ST Elevation Acute Coronary Syndrome.

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT00769574

Enrollment

143

Registered

2008-10-09

Start date

2008-06-30

Completion date

2011-08-31

Last updated

2014-08-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coronary Syndrome

Brief summary

To assess diagnostic and prognostic value of new biomarkers in patients admitted for suspicion of non ST elevation acute coronary syndrome (NSTE ACS).

Interventions

OTHERBiological analysis of biomarkers

Biological analysis of biomarkers

Study design

Allocation

NON_RANDOMIZED

Intervention model

PARALLEL

Primary purpose

DIAGNOSTIC

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* subjects over 18 years, * subject about having a chest pain of coronary syndrome, * subject about not having received heparin or LMWH

Exclusion criteria

* subject minor * subject without informed consent, * subject after receiving an anticoagulant treatment, * transplanted heart, kidney or liver

Design outcomes

Primary

Measure	Time frame
To assess diagnostic and prognostic value of new biomarkers in patients admitted for suspicion of non ST elevation acute coronary syndrome (NSTE ACS).	24 months

Secondary

Measure	Time frame
Compare the characteristics of biological markers to those of usual or innovative markers	24 months

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026